MARKET

PDPHF

PDPHF

EGETIS THERAPEUTICS AB
No Tier
--
0.00
0.00%
Closed 09:30 04/27 EDT
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
0.0000
52 WEEK LOW
0.0000
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
No Data
About PDPHF
Egetis Therapeutics AB (publ), formerly PledPharma AB (publ) is a Sweden-based pharmaceutical drug development company, focusing on projects in late-stage development for treatment of diseases with unmet medical needs in the orphan drug segment. The Company’s pipeline include Emcitate developed for the treatment of MCT8 deficiency, PledOx developed to reduce nerve damage associated with chemotherapy and Aladote developed to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning.

Webull offers Egetis Therapeutics AB (publ) stock information, including No Tier: PDPHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDPHF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PDPHF stock methods without spending real money on the virtual paper trading platform.